Root Valuation
Is ROOT undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ROOT?
Other financial metrics that can be useful for relative valuation.
| What is ROOT's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$79.38m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does ROOT's PB Ratio compare to its peers?
| Company | PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.7x | ||
UIHC United Insurance Holdings | 1x | n/a | US$82.3m |
HRTG Heritage Insurance Holdings | 0.5x | 110.6% | US$63.0m |
ICCH ICC Holdings | 0.8x | n/a | US$45.0m |
PPHI Positive Physicians Holdings | 0.4x | n/a | US$25.3m |
ROOT Root | 0.2x | 19.2% | US$79.4m |
Price-To-Book vs Peers: ROOT is good value based on its Price-To-Book Ratio (0.2x) compared to the peer average (0.7x).
Price to Earnings Ratio vs Industry
How does ROOT's PE Ratio compare vs other companies in the US Insurance Industry?
Price to Book Ratio vs Fair Ratio
What is ROOT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 0.2x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate ROOT's Price-To-Book Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of ROOT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate ROOT's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ROOT's fair value for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$5.88 | US$11.81 +100.8% | 72.9% | US$32.40 | US$4.00 | n/a | 11 |
| Jan ’24 | US$4.49 | US$13.63 +203.5% | 60.6% | US$32.40 | US$6.00 | n/a | 11 |
| Dec ’23 | US$7.05 | US$13.85 +96.5% | 58.3% | US$32.40 | US$8.00 | n/a | 11 |
| Nov ’23 | US$8.07 | US$19.33 +139.6% | 40.3% | US$32.40 | US$9.50 | n/a | 10 |
| Oct ’23 | US$7.88 | US$30.08 +281.8% | 68.8% | US$90.00 | US$15.00 | n/a | 10 |
| Sep ’23 | US$11.40 | US$30.08 +163.9% | 68.8% | US$90.00 | US$15.00 | n/a | 10 |
| Aug ’23 | US$18.90 | US$47.65 +152.1% | 57.2% | US$108.00 | US$22.50 | n/a | 10 |
| Jul ’23 | US$21.24 | US$70.24 +230.7% | 85.5% | US$234.00 | US$27.00 | n/a | 10 |
| Jun ’23 | US$24.66 | US$65.49 +165.6% | 90.3% | US$234.00 | US$18.00 | n/a | 11 |
| May ’23 | US$34.74 | US$67.12 +93.2% | 86.5% | US$234.00 | US$27.00 | n/a | 11 |
| Apr ’23 | US$36.18 | US$68.43 +89.1% | 84.2% | US$234.00 | US$27.00 | n/a | 11 |
| Mar ’23 | US$31.32 | US$81.41 +159.9% | 70.6% | US$234.00 | US$27.00 | n/a | 11 |
| Feb ’23 | US$37.80 | US$117.82 +211.7% | 46.2% | US$234.00 | US$54.00 | n/a | 11 |
| Jan ’23 | US$55.80 | US$123.92 +122.1% | 36.5% | US$234.00 | US$54.00 | US$4.49 | 13 |
| Dec ’22 | US$64.80 | US$123.92 +91.2% | 36.5% | US$234.00 | US$54.00 | US$7.05 | 13 |
| Nov ’22 | US$89.64 | US$130.50 +45.6% | 34.8% | US$234.00 | US$90.00 | US$8.07 | 12 |
| Oct ’22 | US$93.06 | US$132.00 +41.8% | 33.6% | US$234.00 | US$90.00 | US$7.88 | 12 |
| Sep ’22 | US$113.22 | US$131.54 +16.2% | 32.4% | US$234.00 | US$90.00 | US$11.40 | 13 |
| Aug ’22 | US$137.34 | US$270.00 +96.6% | 38.0% | US$540.00 | US$144.00 | US$18.90 | 12 |
| Jul ’22 | US$178.92 | US$288.00 +61.0% | 33.3% | US$540.00 | US$153.00 | US$21.24 | 12 |
| Jun ’22 | US$166.50 | US$297.00 +78.4% | 34.9% | US$540.00 | US$153.00 | US$24.66 | 12 |
| May ’22 | US$193.86 | US$346.15 +78.6% | 30.9% | US$540.00 | US$162.00 | US$34.74 | 13 |
| Apr ’22 | US$219.42 | US$361.38 +64.7% | 28.7% | US$540.00 | US$162.00 | US$36.18 | 13 |
| Mar ’22 | US$248.58 | US$394.50 +58.7% | 19.4% | US$540.00 | US$234.00 | US$31.32 | 12 |
| Feb ’22 | US$382.68 | US$406.50 +6.2% | 19.5% | US$540.00 | US$234.00 | US$37.80 | 12 |
| Jan ’22 | US$282.78 | US$411.00 +45.3% | 19.2% | US$540.00 | US$234.00 | US$55.80 | 12 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.